Focus on skin cancer association and progression under TNF antagonist therapy

Author： Piéérard-Franchimont Claudine   Piéérard Géérald E   Quatresooz Pascale  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.9, 2011-09, pp. : 1215-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring

By  

Current Proteomics, Vol. 10, Iss. 3, 2013-10 ,pp. : 202-217

Bentham Science Publishers

Access to resources Recommend Favorite

Skin Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin Are Mediated via Impairment of Receptor Tyrosine Kinase Signaling and Perturbation in Cell Cycle Progression

By Ahmad N.   Gali H.   Javed S.   Agarwal R.  

Biochemical and Biophysical Research Communications, Vol. 247, Iss. 2, 1998-06 ,pp. : 294-301

Elsevier

Access to resources Recommend Favorite

Sialidase significance for cancer progression

By Miyagi Taeko  

Glycoconjugate Journal, Vol. 29, Iss. 8-9, 2012-12 ,pp. : 567-577

Springer Publishing Company

Access to resources Recommend Favorite

N -Glycans in cancer progression

By Lau Ken S   Dennis James W  

Glycobiology, Vol. 18, Iss. 10, 2008-10 ,pp. : 750-760

Oxford University Press

Access to resources Recommend Favorite

Recombinant TNF-binding protein from variola virus as a novel potential TNF antagonist

By Gileva I.   Nepomnyashchikh T.   Ryazankin I.   Shchelkunov S.  

Biochemistry (Moscow), Vol. 74, Iss. 12, 2009-12 ,pp. : 1356-1362

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite